News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Pharma Cooperates to Achieve Precision Medicine
Catherine Offord | Feb 1, 2017
The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.
Marijuana Research Still Stymied by Federal Laws
Bob Grant | Jan 23, 2017
US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.
Infographic: Repurposing Strategies
Anna Azvolinsky | Dec 31, 2016
Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
FDA OKs Clinical Trials of Ecstasy for PTSD
Joshua A. Krisch | Dec 1, 2016
The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.
Opinion: Not All Genetic Databases Are Equal
Charles M. Strom | Dec 1, 2016
Sorting out which data sets are clinical-grade is key to helping patients.
New Support for Experimental Alzheimer’s Drug
Jef Akst | Nov 2, 2016
Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
Bob Grant | Oct 31, 2016
An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.
European Drug Regulator Releases Clinical Trial Data
Ben Andrew Henry | Oct 21, 2016
In the initial steps of a campaign to make clinical reports publicly available, the European Medicines Agency has published data on two recently approved drugs.